c-myc amplification in ovarian cancer.

[1]  D. E. Groff,et al.  Determination of cellular oncogene rearrangement or amplification in ovarian adenocarcinomas. , 1989, American journal of obstetrics and gynecology.

[2]  G. Moore,et al.  A unique pattern of proto‐oncogene abnormalities in ovarian adenocarcinomas , 1988, Cancer.

[3]  J. Yokota,et al.  Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of disease. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  M. Ishibashi,et al.  Amplification of the c-myc gene and the elevation of its transcripts in human ovarian tumor lines. , 1987, Cell structure and function.

[5]  N. Habib,et al.  The clinical application of molecular biology in colorectal cancer , 1986, Diseases of the colon and rectum.

[6]  C. McArdle,et al.  The relation of ras family oncogene expression to conventional staging criteria and clinical outcome in colorectal carcinoma. , 1986, British Journal of Cancer.

[7]  J. Yokota,et al.  Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation. , 1986, Science.

[8]  M. Viola,et al.  Expression of ras oncogene p21 in prostate cancer. , 1986, The New England journal of medicine.

[9]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[10]  P Chambon,et al.  Isolation of high-molecular-weight DNA from mammalian cells. , 1973, European journal of biochemistry.

[11]  O. Serova.  [Amplification of c-myc proto-oncogene in primary tumors, metastases and blood leukocytes of patients with ovarian cancer]. , 1987, Eksperimental'naia onkologiia.

[12]  M. Cole.  The myc oncogene: its role in transformation and differentiation. , 1986, Annual review of genetics.

[13]  J. Bishop.  Cellular oncogenes and retroviruses. , 1983, Annual review of biochemistry.